Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672294 | SCV000797390 | pathogenic | Xeroderma pigmentosum, group C | 2018-02-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001048861 | SCV001212886 | pathogenic | not provided | 2023-12-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg247*) in the XPC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XPC are known to be pathogenic (PMID: 23173980, 25256075). This variant is present in population databases (rs764321665, gnomAD 0.0008%). This premature translational stop signal has been observed in individual(s) with xeroderma pigmentosum (PMID: 23173980). This variant is also known as c.843C>T. ClinVar contains an entry for this variant (Variation ID: 556301). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000672294 | SCV004207013 | pathogenic | Xeroderma pigmentosum, group C | 2022-10-08 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000672294 | SCV005016546 | pathogenic | Xeroderma pigmentosum, group C | 2024-03-14 | criteria provided, single submitter | clinical testing |